Understanding Menstrual Hormones and Oral Contraceptive Choices
|
|
- Nathaniel Fleming
- 7 years ago
- Views:
Transcription
1
2 Understanding Menstrual Hormones and Oral Contraceptive Choices ACTIVITY DESCRIPTION Pharmacists should be aware of the various types of oral contraceptives that are currently available and how to choose among them. They should also be aware of the warnings, contraindications and potential side effects of this class of medication. TARGET AUDIENCE The target audience for this activity is pharmacists, pharmacy technicians, and nurses in hospital, community, and retail pharmacy settings. LEARNING OBJECTIVES After completing this activity, the pharmacist will be able to: Summarize the pathway of the normal menstrual cycle and its relation to the mechanism of action of oral contraceptives. Compare and contrast the oral contraceptives that are currently available Explain the health benefits and risks associated with oral contraceptive use. List the potential drug-drug interactions associated with oral contraceptive Counsel a patient on oral contraceptive use including missed doses and adherence issues. After completing this activity, the pharmacy technicians will be able to: Summarize the menstrual cycle List oral contraceptives currently available ACCREDITATION Pharmacy PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Nursing PharmCon, Inc. is approved by the California Board of Registered Nursing (Provider Number CEP 13649) and the Florida Board of Nursing (Provider Number ). Activities approved by the CA BRN and the FL BN are accepted by most State Boards of Nursing. CE hours provided by PharmCon, Inc. meet the ANCC criteria for formally approved continuing education hours. The ACPE is listed by the AANP as an acceptable, accredited continuing education organization for applicants seeking renewal through continuing education credit. For additional information, please visit: Universal Activity No.: H01-P Credits: 1.0 Release Date: 7/05/2016 freece Expiration Date: 7/05/2018 ACPE Expiration Date: 1/05/2019 ACTIVITY TYPE Knowledge-Based Live Webinar FINANCIAL SUPPORT BY PharmCon
3 Brooke Fidler Assistant Professor, LIU Pharmacy, Arnold & Marie Schwartz College of Pharmacy and Health Sciences ABOUT THE AUTHOR Dr. Brooke Fidler joined the faculty in 2000 as assistant professor of pharmacy practice. In 1999 Dr. Fidler completed a Pharm.D. at the University of Rhode Island and went on to complete a PGY-1 residency at URI the following year. Currently Dr. Fidler s practice site is Kings Specialty Pharmacy where she precepts APPE students completing their MTM elective experience. At Kings Pharmacy Dr. Fidler is also the residency director for the PGY-1 Community Residency. Dr. Fidler s primary didactic responsibilities including teaching and coordinating the physical assessment course at the college. Dr. Fidler has published in Pharmacy and Therapeutics Journal and Journal of Nurse Practitioners. She has also presented numerous webinars for Drug Store News and FreeCE related to community practice and nonprescription medications. FACULTY DISCLOSURE It is the policy of PharmCon, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) and/or service(s) discussed in an educational activity. Brooke Fidler reports no actual or potential conflict of interest in relation to this activity. Peer review of the material in this CE activity was conducted to assess and resolve potential conflict of interest. Reviewers unanimously found that the activity is fair balanced and lacks commercial bias. Please Note: PharmCon, Inc. does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced and objective. Occasionally, faculty may express opinions that represent their own viewpoint. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not intended as a substitute for the participant s own research, or for the participant s own professional judgement or advice for a specific problem or situation. Conclusions drawn by participants should be derived from objective analysis of scientific data presented from this activity and other unrelated sources. Neither freece/pharmcon nor any content provider intends to or should be considered to be rendering medical, pharmaceutical, or other professional advice. While freece/pharmcon and its content providers have exercised care in providing information, no guarantee of it s accuracy, timeliness or applicability can be or is made. You assume all risks and responsibilities with respect to any decisions or advice made or given as a result of the use of the content of this activity.
4 Understanding Menstrual Hormones and Oral Contraceptive Choices Understanding Menstrual Hormones and Oral Contraceptive Choices Activity Universal Activity Number Activity Faculty ACCREDITATION L01-P INSTRUCTION Credits Brooke Fidler, PharmD 1.0 contact hour(s) Assistant Professor of Pharmacy Practice, LIU Pharmacy Faculty Disclosure Dr. Fidler has no actual or potential conflicts of interest in relation to this activity. Learning OBJECTIVES Review the pathway of the normal menstrual cycle and its relation to the mechanism of action of oral contraceptives (OCs) Compare and contrast the oral contraceptives that are currently available Explain the health benefits and risks associated with oral contraceptive use List the potential drug-drug interactions associated with oral contraceptives Describe the key counseling points for a patient taking oral contraceptives including missed doses and adherence issues Legal DISCLAIMER The material presented here does not necessarily reflect the views of PharmCon, Inc. or the companies that support educational programming. A qualified healthcare professional should always be consulted before using any therapeutic product discussed. Participants should verify all information and data before treating patients or employing any therapies described in this educational activity. FACULTY: Brooke D Fidler, PharmD 7/5/ Learning Objectives Review the pathway of the normal menstrual cycle and its relation to the mechanism of action of oral contraceptives (OCs) Compare and contrast the oral contraceptives that are currently available Explain the health benefits and risks associated with oral contraceptive use List the potential drug-drug interactions associated with oral contraceptives Describe the key counseling points for a patient taking oral contraceptives including missed doses and adherence issues Background According to the CDC between % of 60.9 million women aged in the US use a method of contraception OCs (16%), female sterilization (15.5%), male condom (9.4%), long acting reversible contraceptives (7.2%) Approximately 15% of OC users show poor compliance Failure to fill prescription or late refills Incorrect administration and missed doses Discontinuing the OC with no or poor backup method 7/5/ /5/
5 Role of the Pharmacist Choosing the appropriate oral hormonal contraceptive based on patient characteristics Counseling on potential side effects Educating patients on risks vs benefits Counseling on proper administration and missed doses Identifying issues of non-adherence Identifying potential drug interactions History of Oral Contraceptives 1960 s First combined oral contraceptive (COC) marketed Production of high and fixed dose of E/P 1970 s First progestin-only pill (POP) marketed Production of lower dose E/P in COC Recognizing COC use for postcoital contraception (Yuzpe regimen) 1980 s First COC marketed with varied dose of either or both E/P 7/5/ /5/ History of Oral Contraceptives Late 1980 s Non-contraceptive benefits of OCs are recognized 1990 s Continued production of low-dose COC 1997 FDA identifies certain COCs safe and effective to use as EC Some COCs approved for treatment of acne History of Oral Contraceptives 1999 Approval of Plan B emergency contraceptive (EC) 2003 and 2006 Extended duration COC (I.e., Seasonale and Seasonique ) 2013 Unrestricted OTC sale for oral emergency contraception 7/5/ /5/
6 Normal Menstrual Cycle Normal Menstrual Cycle The first day of menses is Day 1 of the menstrual cycle Average cycle is 28 days, between days Average menses is 5 days, between 3-10 days 3 Phases: follicular, ovulation, luteal 3 Cycles: pituitary, ovarian, endometrial Hormones: follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, progesterone Phases Follicular (preovulatory) Ovulatory Luteal (postovulatory) Cycles Pituitary Ovarian Endometrial Hormones FSH LH Estrogen Progesterone 7/5/ /5/ Normal Menstrual Cycle Release of FSH and LH, increase production of estrogen (thinning of cervical mucus) Release of egg, production of progesterone OCs and Menstrual Cycle Suppress LH and FSH Inhibit ovulation Increased production of progesterone and thickening of uterine lining 7/5/ Thicken cervical mucus and prevents thickening of endometrial lining Lighter menstrual flow 7/5/
7 Hormonal Birth Control Options Progestin-only Progestin-only pill (POP or minipill) Injection IUD Estrogen + Progestin Combination Oral Contraceptive (COC) Vaginal ring Transdermal POP Mechanism of Action Only contains progestin as active ingredient Thickens cervical mucus to inhibit sperm penetration Prevents thickening of the endometrium lining to inhibit fertilized egg from implanting in the uterus Suppresses ovulation in half of users Lowers mid-cycle LH and FSH peaks Slows movement of ovum through fallopian tube 7/5/ /5/ COC Mechanism of Action Contains estrogen and progestin (E+P) as active ingredients Inhibition of ovulation by suppressing LH and FSH Thickens cervical mucus to increase the difficulty of sperm entering into the uterus Thinning of the endometrium lining to prevent a fertilized egg from implanting in the uterus Progesterone First generation (estrane) Norethindrone, norethindrone acetate, ethynodiol diacetate Second generation (gonane) Levonorgestrel, norgestrel Third generation (newer gonane) Desogestrel, norgestimate Fourth generation Drospirenone (spironolactone derived), dienogest 7/5/ /5/
8 Estrogen Ethinyl estradiol (EE) is the synthetic estrogen used in COCs Daily EE doses in COC have greatly decreased over the years 50mcg, 35mcg, 30mcg, 20 mcg, 10mcg Due to risk of venous thromboembolism patients should not take more than 50 mcg/day of ethinyl estradiol Estradiol valerate/dienogest (Natazia ) approval for contraception and heavy menstrual bleeding 7/5/ Commercially Available Products * POP Norethindrone (Errin, Nor-QD ) COC (P+EE) Norethindrone ** (Junel, Loestrin, Microgestin, Necon ) Ethynodiol diacetate (Zovia, Kelnor ) Levonorgestrel^ (Camrese, Lessina, Seasonale ) Norgestrel (Cryselle, Low-Ogestrel ) Desogestrel (Apri, Kariva ) Norgestimate ** (Ortho Tri-Cyclen, Tri-Sprintec, Previfem ) Drospirenone ** (Ocella, Yasmin, Yaz, Beyaz ) * List is not comprehensive; **Can be used for acne treatment; ^Can be used for EC 7/5/ Progestin Properties Potency (relative to 1mg of norethindrone) Desogestrel, levonorgestrel, norgestrel Estrogenic activity Ethinyl estradiol >35 mcg Progestational activity (relative to 1mg of norethindrone) Desogestrel, levonorgestrel, norgestrel Androgenic activity Low: desogestrel, norgestimate, norethindrone (<1mg), drospirenone Moderate: levonorgestrel, ethynodiol, norethindrone (1mg) High: norgestrel, norethindrone (>1mg) Oral Contraceptive Properties Too much estrogen Nausea, bloating, breast tenderness, increased BP and headache, weight gain, heavy menstrual flow, cardiovascular events (MI, VTE) Too little estrogen Early-cycle spotting or breakthrough bleeding (BTB), vaginal dryness, amenorrhea Too much progestin Breast tenderness, headache, weight gain, hirsutism, mood changes Too little progestin Late BTB, heavy menstrual flow, amenorrhea Too much androgen Increased appetite, weight gain, acne, oily skin, decreased libido, increase cholesterol, hirsutism, fatigue 7/5/ /5/
9 COC Products Monophasic (Ovcon, Necon, Loestrin, Desogen ) Constant dose of both E+P in each active pill throughout the entire cycle EE 20-50mcg/day Biphasic (Ortho-Novum,Kariva ) Contains 2 different progestin doses and estrogen remains constant Contain 2 different estrogen doses and progestin remains constant COC Products Triphasic (Ortho Tri-Cyclen, Tri-Sprintec ) Gradual increase of E and/or P throughout cycle Four-phasic (Natazia ) 4 progestin/estrogen dosing combinations throughout cycle 7/5/ /5/ Day COC Formulation 21 active tablets with a 7 day inactive week Inactive week No tablets (21 day container) Placebo tablets (28 day container) Iron tablets (Estrostep Fe ) Folate tablets (Beyaz ) Imitates the normal menstrual cycle Withdrawal bleeding during the inactive week (1 period every 4 weeks) 84 Day COC Formulation Seasonale, Seasonique 84 active tablets with a 7 day inactive week (91 day container) Decreases withdrawal bleeding to 4 per year Eliminate or reduce PMS symptoms, dysmenorrhea and other symptoms associated with withdrawal period 7/5/ /5/
10 POP Products Taken continuously with no inactive weeks (28 day container) Contains norethindrone 0.35mg Brand products include by not limited to Ortho Micronor, Camila, Errin, Jencycla, Nor-QD Bleeding using POP varies among women No bleeding, regular or irregular bleeding Noncontraceptive Benefits of OCs Reduce risk of ovarian cancer Treatment of endometriosis Treatment of PCOS Reduce risk of endometrial cancer Reduce risk of colorectal cancer Improvement in acne 7/5/ /5/ Noncontraceptive Benefits of OCs Menstrual benefits (PMS, PMDD, anemia) Protection of pelvic inflammatory disease Reduce incidence of ectopic pregnancy Positive effects on bone mineral density and reduction in hip fractures Transition therapy for perimenopausal women Cardiovascular and OC Health Risks Venous thromboembolism (VTE) Increases risk by 3-6 fold Other risk factors include age >35, obesity, family history MI OC users and smoke >15 cigarettes/day OC users with HTN are 1.5 times more likely to have stroke Other risk factors include obesity, diabetes, hyperlipidemia and age >35 Stroke Risk is 3 times higher in OC users Risk increases to 7 times in OC users who smoke and have HTN 7/5/ /5/
11 Cancer and OC Health Risks Breast cancer Increase risk initially and may decrease to that of a nonuser after discontinuation Risk was seen to be higher in those using triphasic OCs Caution in patients with a family history Liver disease May be associated with a duration of use for longer than 5-8 years but still remains unclear Cervical cancer Associated with a duration of use for longer than 5-8 years Risk is 4 times higher when used OC for longer than 10 years Metabolic and OC Health Risks Diabetes Does not seem to cause diabetes but can worsen DM Estrogen can increase glucose levels and suppresses insulin response Progestin stimulates insulin production Linked to more androgenic properties Lipids OCs can affect LDL, HDL, TG and HDL 7/5/ /5/ Misc. OC Health Risks Gallbladder disease Associated with high dose estrogen Increase formation of gallstones and inflammation of gallbladder Migraine Associated with high dose estrogen Warning sign of stroke Visual changes (retinal thrombosis) Does not protect against HIV or other STDs Minor hormonal side effects COC Contraindications Thrombophlebitis or thromboembolic disease Past history of DVT or thromboembolic disorders CVD or CAD Known or suspected carcinoma of the breast Carcinoma of the endometrium or suspected estrogen-dependent neoplasia Undiagnosed abnormal genital bleeding Cholestatic jaundice of pregnancy or jaundice with prior pill use Hepatic adenomas or carcinomas Known or suspected pregnancy Hepatic or renal dysfunction or adrenal insufficiency (drospirenone) 7/5/ /5/ Guidance for Industry. Labeling for COC. FDA. 8
12 COC Black Box Warning Women >35 years of age who smoke Smoking increases the risk of CV events from COC use Risk increases with number of cigarettes smoked COC Warnings and Precautions Persistent high blood pressure (>160/100) History of diabetes History of dyslipidemia History of migraines History of gallbladder disease 7/5/ Guidance for Industry. Labeling for COC. FDA. 7/5/ Guidance for Industry. Labeling for COC. FDA. WHO Contraindications Those listed in the PI plus Lactation (<6 weeks postpartum) Age >35 and smokes > 15cigarettes/day Elevated BP (>160/>100) Chest pain (angina pectoris) CVD or CAD Major surgery with prolonged immobilization Complicated valvular heart disease Migraine without focal neurologic symptoms >35 years Migraine with focal neurologic symptoms at any age Complicated diabetes (microvascular disease or >20 years duration Severe cirrhosis 7/5/ POP Contraindications Pregnancy History or current breast cancer Undiagnosed abnormal genital bleeding Currently taking antiseizure or TB medications Allergic to product Benign or cancerous liver tumors Acute liver disease Thromboembolic disorders 7/5/ POP Package Inserts. FDA. 9
13 POP Warnings Breastfeeding within 6 weeks of postpartum Ovarian cysts Smoking (BBW due to risk of MI and stroke) Diabetes Which OC is right OC for me? Patient characteristics Age, weight, smoker, BP, lipids, history of cancers, history of CVD, history of migraines, menstrual history, post-partum, breastfeeding, other specific co-existing conditions Tests needed before initiation BMI, BP, clinical breast exam, cervical exam, glucose, liver enzymes, STD/HIV screening 7/5/ POP Package Inserts. FDA. 7/5/ Resources Medical Eligibility Criteria for Contraceptive Use 2006 (reaffirmed in 2013) ACOG published guidelines for use of hormonal contraceptives in women with comorbidities 2010 CDC adapted the WHO US Medical Eligibility Criteria for Contraceptive Use 2013 US Selected Practice Recommendations for Contraceptive Use 1 = A condition for which there is no restriction for the use of the contraceptive method. 2 = A condition for which the advantages of using the method generally outweigh the theoretical or proven risks. 3 = A condition for which the theoretical or proven risks usually outweigh the advantages of using the method. 4 = A condition that represents an unacceptable health risk if the contraceptive method is used. 7/5/ /5/
14 When are POP safer than COC? >35 years Smokers Poorly controlled HTN Obesity Migraines with neurological symptoms Diabetes with complications History of blood clots Any contraindication to COC Breastfeeding Postpartum Postpartum and Contraceptive Use Nonbreastfeeding <21 days should not use hormonal contraceptives (4) days plus risk factors for VTE should not use hormonal contraceptives (3) days without VTE risk factors (2) or >42 days no restrictions (1) Breastfeeding <21 days should avoid use due to concerns of estrogen on breastfeeding and milk production (4) 21 to <30 days with or without other risk factors for VTE avoid use (3) days with VTE risk factors (3) >42 days (2) 7/5/ /5/ COC Side Effects and Resolution COC Side Effects and Resolution Break-through bleeding Higher estrogen, higher progestin potency, less androgenic Menstrual related symptoms (tiredness, bloating, excessive bleeding) Use of extended cycles COC Acne Higher estrogen and less androgenic progestin Absent or light menstrual flow Lower progestin potency Headaches Lower estrogen, lower progestin potency Breast soreness Lower estrogen, lower progestin potency Weight gain Lower estrogen, lower progestin potency Severe menstrual cramps Higher progestin potency Endometriosis Lower estrogen, higher progestin potency, higher androgen potency 7/5/ /5/
15 Special Populations and Recommendations Age COC or POP for >35 years, nonsmoker and no contraindications HTN 3 rd or 4 th generation COC or POP Obesity COC or POP, assess comorbidities Special Populations and Recommendations Smoker Risk vs benefit for <35 years COC considered a contraindication (WHO) and BBW (PI) Warning for POP Minimize risk of VTE Use low estrogen dose or POP Diabetes Use less androgenic progestin or POP 7/5/ /5/ Special Populations and Recommendations Epilepsy or depressive disorders COC or POP and assess for drug interactions Lupus Do not use hormonal OC if positive antiphospholipid antibodies Headaches (with no neurological symptoms) Use low estrogen dose or POP Known hyperlipidemias Use less androgenic progestin Adolescents and OCs High rates of unintended pregnancies and STDs More likely to discontinue OC due to side effects More likely to have poor adherence Discuss barrier method plus OC to prevent STDs and HIV Long-acting injectables (Depo-Provera ) and implantables (Nexplanon ) may provide better adherence Use appropriate E:P ratio for OCs 7/5/ /5/
16 OC Drug Interactions Mechanism of Action Liver metabolism Hormone metabolism via CYP 450 3A4 system 3A4 enzyme inducers metabolism of E/P hormone blood levels effectiveness of COC or POP Enterohepatic circulation Intestinal bacterial breakdown free estrogen for reabsorption via enterohepatic circulation Antibiotics alter intestinal bacteria interrupts reabsorption amount of circulating estrogen effectiveness of COC Drug Interactions with POP Hepatic enzyme-inducing drugs (i.e., phenytoin, carbamazepine, barbiturates and rifampin) No significant interaction with broad-spectrum antibiotics St. John s Wort and induce hepatic enzymes and p-glycoprotein transporters and reduce effectiveness of OCs Concurrent use of bosentan and norethindrone containing OCs may reduce effectiveness of OC 7/5/ /5/ POP Package Inserts. FDA. Drug Interactions with COC Recommendations Reduced efficacy associated with concomitant use of rifampin Reduced efficacy suggested with barbiturates, phenylbutazone, phenytoin, carbamazepine Reduced efficacy possibly with griseofulvin, ampicillin and tetracyclines Short-term antibiotic therapy (less than 2 weeks) Use second method (i.e., condoms or abstinence) with OC during ANY antibiotic therapy and for at least 7 days thereafter Long-term antibiotic therapy Use different method of birth control Use a second method with OC for at least 2 weeks after starting antibiotic therapy 7/5/ COC Package Inserts. FDA. 7/5/
17 Special Populations Epilepsy May require higher dose of estrogen or minimum of 30mcg of estrogen in COC Second method in addition to COC or POP Progesterone only injectable and implant recommended Lamotrigine preferred HIV 1 Always use condoms regardless of contraceptive method May depend on what regimen the patient is taking Intrauterine devices may be most appropriate option Role of the Pharmacist Counseling Provide a private area for discussion Match counseling to individual risk factors (I.e., smoking, HTN) Develop a regular pill-taking regimen Discuss back-up methods of contraception and what to do if pills are missed Be aware of side effects A- abdominal pain (severe) C- chest pain (severe), cough, SOB, sharp pain upon breathing H- headache (severe), dizziness, weakness or numbness E- eye problems (vision loss or blurring), speech problems S- severe leg pain (calf or thigh) 1 Aidsinfo.nih.gov. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents: Drug Interactions. 7/5/ /5/ Initiation of OCs POP Day-1 start regimen (first day of the menstrual period) COC Day-1 start regimen (first day of the menstrual period) Sunday-start regimen (first Sunday after menstrual bleeding begins) POP Missed Pills If you are more than 3 hours late or you missed 1 or more pills Take a missed pill as soon as you remember Then continue your regular regimen Use a backup method every time you have sex for the next 48 hours 7/5/ /5/
18 COC Missed Pills COC Missed Pills No. of COC pills missed Start regimen Time in cycle What to do? Counseling No. of COC pills missed Start regimen Time in cycle What to do? Counseling 1 Day 1 Anytime Take pill as soon as remembered Sunday Anytime Take pill as soon as remembered No backup method No backup method 2 Day 1 Week 1 or 2 Take 2 pills as soon as remembered. Take 2 pills the next day. Take 1 pill everyday until finished. Use backup method for 7 days Sunday Week 1 or 2 Same as above Same as above 7/5/ /5/ COC Missed Pills No. of COC pills missed Start regimen Time in cycle 7/5/ What to do? 2 Day 1 Week 3 Discard the rest of pill pack. Start new pack that same day. Sunday Week 3 Take 1 pill everyday until Sunday. On Sunday, discard rest of pack. Start new pack same day. Counseling Use backup method for 7 days. May not have period. Use backup method for 7 days. May not have period. COC Missed Pills No. of COC pills missed Start regimen Time in cycle 7/5/ What to do? 3 or more Day 1 Anytime Discard the rest of pill pack. Start new pack that same day. Sunday Anytime Take 1 pill everyday until Sunday. On Sunday, discard rest of pack. Start new pack same day. Counseling Use backup method for 7 days. May not have period. Use backup method for 7 days. May not have period. 15
19 Additional Backup Method Patient Information Resources First 7 days after initially starting OC While taking an interacting medication and for 7 days thereafter Prevention of STDs and HIV Severe vomiting or diarrhea (use backup on first day and continue use until next period) The Association of Reproductive Health Professionals Office on Women s Health Food and Drug Administration: Office of Women s health Obstetrics, Gynecology, Infertility and Women's Health The Center for Young Women s Health /5/ /5/ References Current Contraceptive Status Among Women Aged 15 44: United States, Available at U.S. Selected Practice Recommendations for Contraceptive Use, Available at U.S. Medical Eligibility Criteria for Contraceptive Use, Available at The American Congress of Obstetricians and Gynecologists. Available at Bonnema RA et al. Contraceptive Choices in Women with Underlying Medical Conditions. Am Fam Physician. 2010;82(6): Available at 7/5/
20 Exam Questions: 1. What is the maximum dose per day that women should take of ethinyl estradiol due to the risk of thromboembolism? a. 20mcg/day b. 30mcg/day c. 40mcg/day d. 50mcg/day 2. Which of the following progestins is approved for emergency contraception? a. Desogestrel b. Levonorgestrel c. Norgestimate d. Norethindrone 3. Progestin only pills contain which progestin ingredient? a. Desogestrel b. Levonorgestrel c. Norethindrone d. Norgestimate 4. Which of the following risk factors have been shown to further increase the health risks associated with oral contraceptives? a. Smoking b. Obesity c. >35 years of age d. All of the above 5. Which if the following is NOT a benefit of oral contraception? a. Decreased risk of breast cancer b. Reduced risk of ovarian cancer c. Decreased anemia d. Improvement in acne 6. Which of the following statements is TRUE regarding oral contraceptives
21 drug interactions? a. Short-term antibiotic therapy requires use of a second contraceptive method for the duration of treatment only b. Only need to use caution for those medications metabolized by the CYP450 system c. A second contraceptive method should be used during and 7 days after any antibiotic treatment d. Progestin only pills have no significant drug interactions 7. A patient who misses 1 COC pill anytime in their cycle should be counseled to do which of the following? a. Discard the rest of the pill pack and use a backup contraceptive method for 48 hours b. Take the pill as soon as they remember and no backup contraceptive is necessary c. Wait till the next day and take two pills and no backup contraceptive method necessary d. Discard the rest of the pill pack and start a new pack that same day 8. A 25-year-old patient who experiences migraines without neurological symptoms would benefit from which of the following OC profile? a. Lower estrogen dose b. Lower progestin potency c. A and B d. None of the above. OC s would be contraindicated in this patient. 9. Which of the following is a black box warning for COCs? a. Persistent high blood pressure b. History diabetes c. Women >35 years of age who smoke d. History of dyslipidemia 10. A woman who is postpartum, not breastfeeding and has no additional risks for VTE should wait how long before using COC with no additional risks? a days postpartum
22 b. <21 days postpartum c. 30 days postpartum d. >42 days postpartum
Combination Birth Control Pills - FAQ
Combination Birth Control Pills - FAQ How does the birth control pill work? prevents ovulation thickens cervical mucus, which makes it hard for sperm to enter the uterus thins the lining of the uterus,
More informationPILLS & RING INFORMATION AND INSTRUCTIONS ON COMBINED HORMONAL CONTRACEPTION INCLUDING BIRTH CONTROL PILLS & NUVA RING
PILLS & RING INFORMATION AND INSTRUCTIONS ON COMBINED HORMONAL CONTRACEPTION INCLUDING BIRTH CONTROL PILLS & NUVA RING What is combined hormonal contraception? Birth control which contains two hormones
More informationFDA-Approved Patient Labeling
FDA-Approved Patient Labeling Guide for Using Lo Loestrin Fe WARNING TO WOMEN WHO SMOKE Do not use Lo Loestrin Fe if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious
More informationThe Challenges, Risks, and Benefits of Oral Contraceptives
The Challenges, Risks, and Benefits of Oral Contraceptives Learning Objectives After participating in this educational activity, participants should be better able to: 1. Identify the currently available
More informationHormonal Oral Contraceptives: An Overview By Kelsie Court. A variety of methods of contraception are currently available, giving men and
Hormonal Oral Contraceptives: An Overview By Kelsie Court A variety of methods of contraception are currently available, giving men and women plenty of options in choosing a method suitable to his or her
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Birth Control Pills
Birth Control Pills WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Birth control pills (also called oral contraceptives or "the pill") are used by millions of women in the United States to
More informationDrospirenone and Ethinyl Estradiol Tablets USP, 3 mg/ 0.03 mg
FDA Approved Patient Labeling Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/ 0.03 mg Rx only Guide for Using Drospirenone and Ethinyl Estradiol Tablets WARNING TO WOMEN WHO SMOKE Do not use drospirenone
More informationAnatomy and Physiology of Human Reproduction. Module 10a
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationFDA-Approved Patient Labeling IMPLANON (etonogestrel implant) Subdermal Use
FDA-Approved Patient Labeling IMPLANON (etonogestrel implant) Subdermal Use IMPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases. Read this
More informationprogestog progestogen stogen-only pill progestogen progestogen-only pill he progestogen-only pill progestogen-onl progestogen-o the progestogenonly
your guide to the progestogenonly pill Helping you choose the method of contraception that is best for you the progestogen rogestogen-only the progestogen-only pill progestogen-only pill stogen-only progestoge
More informationWhat s New in Contraception? Evelyn Kieltyka, Maine Family Planning, ekieltyka@mainefamilyplanning.org
What s New in Contraception? Evelyn Kieltyka, Maine Family Planning, ekieltyka@mainefamilyplanning.org WHAT S NEW IN CONTRACEPTION? EVELYN KIELTYKA, MSN, MS, FNP 1 2 CONTRACEPTIVES FOR TEENS: THE NEW PARADIGM
More informationCYCLESSA Tablets (desogestrel and ethinyl estradiol tablets USP)
DETAILED PATIENT PACKAGE INSERT CYCLESSA Tablets (desogestrel and ethinyl estradiol tablets USP) 28 Day Regimen This product (like all oral contraceptives) is intended to prevent pregnancy. It does not
More informationAll methods of birth control are MUCH SAFER than being pregnant! If 100 women use each method for a year, how many of them get pregnant?
The Correct Use of Birth Control: In order for any method of birth control to be effective, it must be used correctly ALL THE TIME. This means: One condom every time you have sex One pill every day One
More informationCONSUMER INFORMATION IMPORTANT: PLEASE READ
CONSUMER INFORMATION Pr MICRONOR norethindrone tablets, USP This leaflet is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about MICRONOR. Contact your
More informationPROVERA (medroxyprogesterone acetate) Product Monograph Page 34 of 38
PART III: CONSUMER INFORMATION PR PROVERA* (medroxyprogesterone acetate) This leaflet is part III of a three-part "Product Monograph" published when PROVERA was approved for sale in Canada and is designed
More informationOral Contraceptive PATIENT EDUCATION SERIES
Oral Contraceptive PATIENT EDUCATION SERIES The introduction of oral contraceptives was one of the most transformative developments in the history of women s health. Since introduced in May of 1960, these
More informationCombined Oral Contraceptives
CHAPTER Combined Oral Contraceptives Key Points for Providers and Clients y Take one pill every day. For greatest effectiveness a woman must take pills daily and start each new pack of pills on time. y
More informationLO/OVRAL & LO/OVRAL-28 TABLETS (norgestrel and ethinyl estradiol tablets)
LO/OVRAL & LO/OVRAL-28 TABLETS (norgestrel and ethinyl estradiol tablets) only This product s label may have been revised after this insert was used in production. For further product information and current
More informationNEW UPDATES IN OTC PRODUCTS: 2014 DONALD SULLIVAN, PHARMD
NEW UPDATES IN OTC PRODUCTS: 2014 DONALD SULLIVAN, PHARMD NEW UPDATES IN OTC PRODUCTS: 2014 ACTIVITY DESCRIPTION The program will discuss recently marketed OTC products including their place in therapy,
More informationPost-Coital Hormonal Contraception Instructions for Use of Plan B, Plan B One-Step, Next Choice One Dose, My Way, Generic Levonorgestrel and Ella
Post-Coital Hormonal Contraception Instructions for Use of Plan B, Plan B One-Step, Next Choice One Dose, My Way, Generic Levonorgestrel and Ella Several options for emergency birth control exist for women
More informationBirth Control Options
1 of 5 6/2/2014 9:46 AM Return to Web version Birth Control Options What is contraception? Contraception means preventing pregnancy, also called birth control. Most people know about options such as birth
More informationQuick Guide to Contraception
The New York City Department of Health and Mental Hygiene 2012 EDITION Quick Guide to Contraception For Clinicians in Any Specialty Start Contraception at Today s Visit Safely and Easily Featuring New
More informationA REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D
A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D A REVIEW OF FEDERAL PHARMACY LAW ACTIVITY DESCRIPTION This program will discuss the federal legal requirements for dispensing controlled substances
More informationSTANDARD APRN PROTOCOL FOR IUD INSERTION: Levonorgestrel (LNG) Releasing Intrauterine System
STANDARD APRN PROTOCOL FOR IUD INSERTION: Levonorgestrel (LNG) Releasing Intrauterine System DEFINITION The LNG-releasing intrauterine systems (Mirena, Liletta and Skyla ) are on the market. The LNG-releasing
More informationYoung Women and Long-Acting Reversible Contraception. Safe, Reliable, and Cost-Effective Birth Control
ISSUES AT A GLANCE Young Women and Long-Acting Reversible Contraception Safe, Reliable, and Cost-Effective Birth Control In 2012, the American College of Obstetricians and Gynecologists (ACOG) revised
More informationDr. Friedman s Guide to Estrogen Replacement
Dr. Friedman s Guide to Estrogen Replacement There are risks and benefits with all medicines and estrogen replacement is no exception. In fact, estrogen replacement is one of the most controversial topics
More informationNATURAL MEDICINES TO MANAGE DIABETES
NATURAL MEDICINES TO MANAGE DIABETES ACTIVITY DESCRIPTION Some surveys have shown that more than 60 percent of people with diabetes use some type of supplement. There are many supplements which are traditionally
More informationEffective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion.
Effective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion. After the abortion I started re-thinking my birth control method. I am looking
More informationimplant contraceptiv contraceptive contraceptive raceptiv contraceptive implant contraceptive contraceptive ontraceptive implant ontraceptive im
your guide to the contraceptive implant Helping you choose the method of contraception that is best for you contra ontraceptive im contraceptive implant mpl ceptive contraceptive contracepti ntraceptive
More informationManagement of Abnormal Uterine Bleeding in Adolescents
Management of Abnormal Uterine Bleeding in Adolescents Pamela S. Greene, M.D. Medical Director, Scott & White Hospital Forensic Program Assistant Professor, Texas A&M Health Science Center Department of
More informationHull & East Riding Prescribing Committee
Hull & East Riding Prescribing Committee Guideline on Prescribing of Gonadorelin (GnRH) Analogues and Progesterone Receptor Modulators in treatment of Endometriosis or prior to Endometrial Ablation, or
More informationMenopause and Hormone Replacement Therapy
Menopause and Hormone Replacement Therapy Daniel Breitkopf, MD Department of Obstetrics and Gynecology University of Texas Medical Branch Galveston, Texas USA Objectives Define the indications and contraindications
More informationINFORMATION FOR THE PATIENT PATIENT PACKAGE INSERT CLÉO -35 Acne Treatment
INFORMATION FOR THE PATIENT PATIENT PACKAGE INSERT CLÉO -35 Acne Treatment Composition CLÉO -35 is a preparation which contains 2 sex hormones, cyproterone acetate and ethinyl estradiol in a specific ratio.
More informationOH MY ACHING BODY: TACKLING FIBROMYALGIA GENEVA BRIGGS, PHARMD, BCPS
OH MY ACHING BODY: TACKLING FIBROMYALGIA GENEVA BRIGGS, PHARMD, BCPS OH MY ACHING BODY: TACKLING FIBROMYALGIA ACTIVITY DESCRIPTION Fibromyalgia dramatically impacts the lives of those affected. This program
More informationThis is Jaydess. Patient Information. What is Jaydess? How does Jaydess work?
, Patient Information This is Jaydess We hope that this brochure will answer your questions and concerns about Jaydess. What is Jaydess? Jaydess is an intrauterine device consisting of a hormone capsule
More informationinjections injections injections injections injections injection injections injections injections tions njections injections injections injections
your guide to contraceptive Helping you choose the method of contraception that is best for you ions ections injection njections injection tions 2 Contraceptive Contraceptive contain a progestogen hormone
More informationWhat Athletic Trainers Need to Know About Gynecology
What Athletic Trainers Need to Know About Gynecology Mona M. Shangold,, M.D. Director The Center for Women s Health and Sports Gynecology Philadelphia, PA Main Topics Normal development and function Effects
More informationPREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT
PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE ACTIVITY DESCRIPTION Medications errors may occur more often than
More informationTESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D.
TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D. TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST
More informationRisk Management Plan
Risk Management Plan Active substance: Drospirenone/ethinylestradiol Version number: 4.0 VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Oral contraception Effective control
More informationPlan B (Levonorgestrel) Tablets, 0.75 mg
Plan B (Levonorgestrel) Tablets, 0.75 mg Rx only for women age 17 and younger For women age 17 and younger, Plan B is a prescription only emergency contraceptive. Plan B is intended to prevent pregnancy
More information1/9 (Translation from Finnish / SK / March 16, 2012)
1/9 (Translation from Finnish / SK / March 16, 2012) JADELLE sine inserter 2 x 75 mg implants Package leaflet Please read this leaflet carefully. It contains information on the preparation and its use.
More informationpatient education Fact Sheet PFS003: Hormone Therapy APRIL 2015
patient education Fact Sheet PFS003: Hormone Therapy APRIL 2015 Hormone Therapy Menopause is the time in a woman s life when she naturally stops having menstrual periods. Menopause marks the end of the
More informationHeavy menstrual bleeding and what you can do about it!
Heavy menstrual bleeding and what you can do about it! The intrauterine system as an alternative to hysterectomy. What is heavy menstrual bleeding? Do I have it? A woman s menstrual periods are considered
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is a disorder that affects as many as 5 10% of women. PCOS has three key features: 1) high levels of hormones called androgens; 2) irregular menstrual
More informationAbnormal Uterine Bleeding FAQ Sheet
Abnormal Uterine Bleeding FAQ Sheet What is abnormal uterine bleeding? Under normal circumstances, a woman's uterus sheds a limited amount of blood during each menstrual period. Bleeding that occurs between
More informationNow that your Doctor has prescribed Livial for you
Now that your Doctor has prescribed Livial for you This educational brochure is only for use by patients prescribed LIVIAL The Menopause The term menopause refers to the very last menstrual period a woman
More informationPOLYCYSTIC OVARY SYNDROME
POLYCYSTIC OVARY SYNDROME Information Leaflet Your Health. Our Priority. Page 2 of 6 What is polycystic ovary syndrome? (PCOS) Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women
More informationPolycystic Ovarian Syndrome
Polycystic Ovarian Syndrome What is Polycystic Ovarian Syndrome? Polycystic ovary syndrome (or PCOS) is a common condition affecting 3 to 5% of women of reproductive age. It is linked with hormonal imbalances,
More informationWomen s Preventive Services
Interim Final Rules for Non-Grandfathered Group Health Plans and Health Insurance Issuers Coverage of Preventive Services under the Patient Protection and Affordable Care Act Women s Preventive Services
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy
Hormone Therapy WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 At menopause, a woman's body makes less estrogen and she stops having menstrual periods. This is a natural stage in a woman's
More informationHEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)
HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Endometriosis
Endometriosis WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The lining of the uterus is called the endometrium. Sometimes, endometrial tissue grows elsewhere in the body. When this happens
More informationAbigail R. Proffer, M.D. October 4, 2013
Abigail R. Proffer, M.D. October 4, 2013 Topics Human Papillomavirus (HPV) Vaccines Pap smears Colposcopy Contraception Polycystic Ovary Syndrome (PCOS) Can I get pregnant? Miscarriage Abnormal Uterine
More informationWhy is Cerazette used? To prevent pregnancy.
CERAZETTE Tablets for oral use Consumer Medicine Information What is in this leaflet Keep this leaflet. You may need to read it again. This leaflet will provide information about the benefits and risks
More informationForm ### Transgender Hormone Therapy - Estrogen Informed Consent SAMPLE
What are the different medications that can help to feminize me? Estrogen - Different types of the hormone estrogen can help you appear more feminine. Estrogen is the female sex hormone. Androgen blocker
More informationON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH
ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH ON PENS AND NEEDLES - A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES ACTIVITY DESCRIPTION Insulin
More informationAbnormal Uterine Bleeding
Abnormal Uterine Bleeding WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Abnormal uterine bleeding is one of the most common reasons women see their doctors. It can occur at any age and has
More informationBE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD
BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES ACTIVITY DESCRIPTION With over 230,000 pharmacists trained
More informationMenstruation and the Menstrual Cycle
Menstruation and the Menstrual Cycle Q: What is menstruation? A: Menstruation is a woman s monthly bleeding, also called a period. When you menstruate, your body is shedding the lining of the uterus (womb).
More informationMenopause Guidance on management and prescribing HRT for GPs based on NICE guidance 2015
PRIMARY CARE WOMEN S HEALTH FORUM GUIDELINES Menopause Guidance on management and prescribing HRT for GPs based on NICE guidance 2015 Written by Dr Imogen Shaw This guidance is designed to support you
More informationvagina vaginal r vaginal ring vaginal vaginal ring aginal ring vaginal ring vaginal ring vaginal ring the contraceptive vaginal rin vaginal ring
your guide to the contraceptive vaginal ring Helping you choose the method of contraception that is best for you vagina vaginal ring vaginal r vaginal ring vaginal ring vaginal rin vaginal aginal ring
More informationOVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH
OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH OVERVIEW OR RECENT PHARMACY LAW CASES ACTIVITY DESCRIPTION This class reviews six legal cases in which allegations were made that pharmacy
More informationUSER PACKAGE LEAFLET: INFORMATION FOR THE USER Exluton, tablets 0.5 mg Lynestrenol
Lynestrenol 0.5mg tablets, (N.V.Organon), RH021 WHOPAR part 3 supplier s translation of original SRA approved text May 2012 USER PACKAGE LEAFLET: INFORMATION FOR THE USER Exluton, Lynestrenol Read this
More informationWHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH
WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES ACTIVITY DESCRIPTION
More informationBirth Control Methods
page 1 Birth Control Methods Q: What is the best method of birth control (or contraception)? A: There is no best method of birth control. Each method has its pros and cons. All women and men can have control
More informationThe menopausal transition usually has three parts:
The menopausal transition usually has three parts: Perimenopause begins several years before a woman s last menstrual period, when the ovaries gradually produce less estrogen. In the last 1-2 years of
More informationPolycystic ovary syndrome (PCOS)
Centre for Diabetes and Endocrinology - Patient information Polycystic ovary syndrome (PCOS) Approximately 1 in 5 women have polycystic ovaries. This describes the appearance of the ovaries when they are
More informationOverview of Existing State Distribution Mechanisms and Barr s Proposed Educational Program and Distribution for Plan B
Overview of Existing State Distribution Mechanisms and Barr s Proposed Educational Program and Distribution for Plan B In most states throughout the US, emergency contraception pills, including Plan B,
More informationANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.
ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest
More informationREVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH
REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS ACTIVITY DESCRIPTION This program will assist pharmacy technicians to understand the
More informationpatch contracep raceptiv contraceptive patch contraceptive patch contraceptiv patch contraceptive patch tch ontraceptive atch contraceptive p
your guide to the contraceptive patch Helping you choose the method of contraception that is best for you contra ontraceptive pat contraceptive patch contraceptive patch ceptive patc atch contrace contracept
More informationMOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH
MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC ACTIVITY DESCRIPTION IBS-C and
More informationGUIDELINE FOR NURSES RE-ISSUING ORAL CONTRACEPTIVE PILLS
GUIDELINE FOR NURSES RE-ISSUING ORAL CONTRACEPTIVE PILLS The purpose of this guideline is to identify those women who can safely be reissued pills by practice nurses without needing to see a doctor. It
More informationFrom Menses to Menopause: How Hormones Can Affect Blood Glucose Levels. Christine Day, RN, MS, CNS-BC Lake Superior College
From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels Christine Day, RN, MS, CNS-BC Lake Superior College Overview Will review hormonal changes over the female lifespan Discuss the effects
More informationcontraception contraception contraception contracepti contraception contraception contraception aception contraception contraception contraception
your guide to Helping you choose the method of that is best for you raception aception contracept contracepti contracep contracepti Your guide to This leaflet shows the available contraceptive methods,
More informationDiary Card. Cerazette. Keeping a record. For women prescribed Cerazette. How do I find out more? www.cerazette.co.uk
Cerazette Keeping a record How do I find out more? You can ask for more information on Cerazette at your doctor s surgery or at family planning clinics. A diary card is attached. We suggest you keep a
More informationency emergency contra-
your guide to emergency contraception Helping you choose the method of contraception that is best for you emergency cont gency contrace emergency contraception ency emergency contra- emergen mergency contraception
More informationMenstruation and the Menstrual Cycle
Menstruation and the Menstrual Cycle Q: What is menstruation? A: Menstruation (men-stray-shuhn) is a woman's monthly bleeding. When you menstruate, your body sheds the lining of the uterus (womb). Menstrual
More informationAccurate Answers. to Questions About Birth Control Pills. Rick Jelovsek MD From BackupMD.net. Table of Contents
Accurate Answers to Questions About Birth Control Pills By Rick Jelovsek MD From BackupMD.net Table of Contents Beginning the pills... 2 How to start... 2 How do the pills work to prevent pregnancy?...2
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION ALESSE 21 and ALESSE 28 100 µg Levonorgestrel and 20 µg Ethinyl Estradiol Tablets This leaflet is part III of a three-part "Product Monograph" published when ALESSE was approved
More informationMEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?
MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of
More informationBACKGROUNDER CONTRACEPTION
BACKGROUNDER CONTRACEPTION DID YOU KNOW?» Approximately 85 out of 100 sexually active women who are not using any contraceptive method will get pregnant within one year. 1» Worldwide 38% of women who become
More informationSHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS
SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? ACTIVITY DESCRIPTION The benefits of increasing intake of omega-3 fatty
More informationCONTRACEPTION LONG-ACTING REVERSIBLE CONTRACEPTIVES LARCS
6 SAND HILL ROAD SUITE 102 FLEMINGTON, NJ 08822 PHONE 908-782-6700 FAX 908-788-5861 CONTRACEPTION LONG-ACTING REVERSIBLE CONTRACEPTIVES LARCS In 2014 the Academy of Pediatrics recommended that long-acting
More informationMedical criteria for IUCD s Based on the WHO MEC (2004- Annexure 3) system a woman s eligibility for IUCD insertion falls in 4 categories. These categ
CLIENT ASSESSMENT Ensure that the woman is not pregnant Determine the length and direction of uterus. Ensure that she does not have gonorrhea and chlamydia, and is not a high risk case of STI s Identify
More informationFACT SHEET. The Polycystic Ovary Syndrome (PCOS) Introduction
FACT SHEET The Polycystic Ovary Syndrome (PCOS) Introduction The polycystic ovary syndrome (PCOS) is the commonest hormonal disturbance to affect women. The main problems that women with PCOS experience
More informationCAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? GENEVA BRIGGS, PHARMD, BCPS
CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? GENEVA BRIGGS, PHARMD, BCPS CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? ACTIVITY DESCRIPTION
More informationOVARIAN CYSTS. Types of Ovarian Cysts There are many types of ovarian cysts and these can be categorized into functional and nonfunctional
OVARIAN CYSTS Follicular Cyst Ovarian cysts are fluid-filled sacs that form within or on the ovary. The majority of these cysts are functional meaning they usually form during a normal menstrual cycle.
More informationPRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH
PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE ACTIVITY DESCRIPTION This monograph
More informationOvarian Cyst. Homoeopathy Clinic. Introduction. Types of Ovarian Cysts. Contents. Case Reports. 21 August 2002
Case Reports 21 August 2002 Ovarian Cyst Homoeopathy Clinic Check Yourself If you have any of the following symptoms call your doctor. Sense of fullness or pressure or a dull ache in the abdomen Pain during
More informationMHRI IUD Protocol. Migraine with aura Current DVT or PE History of or current breast cancer Active viral hepatitis Severe cirrhosis or liver tumors
Table of Contents A. Indications B. Contraindications C. Prior to Insertion D. Insertion E. Follow-Up Visit F. Removal G. Re-Insertion H. Complications/Side Effects I. Appendices MHRI IUD Protocol A. Indications
More informationEmergency Contraceptive Pills
There are many different forms of birth control available in Canada, many of which we will discuss in this booklet. There is no way to determine which is the best form of birth control, because each person
More informationNEW AND EMERGING THERAPIES IN THE TREATMENT OF SEASONAL ALLERGIES
NEW AND EMERGING THERAPIES IN THE TREATMENT OF SEASONAL ALLERGIES ACTIVITY DESCRIPTION Each year millions of people suffer from the symptoms of allergic rhinitis, which includes annoying running nose,
More informationALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.
ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO
More informationLakeview Endocrinology and Diabetes Consultants. 2719 N Halsted St C-1. Chicago IL 60614 P: 773 388 5685 F: 773 388 5687. www.lakeviewendocrinolgy.
Lakeview Endocrinology and Diabetes Consultants 2719 N Halsted St C-1 Chicago IL 60614 P: 773 388 5685 F: 773 388 5687 www.lakeviewendocrinolgy.com Patient information: Early menopause (premature ovarian
More informationThe Morning-After Pill: The Dangers of Over-the-Counter Availability
The Morning-After Pill: The Dangers of Over-the-Counter Availability Hanna Klaus, M.D. ABSTRACT: In response to a request by Barr Laboratories to market their emergency contraceptive Plan B across the
More informationRHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD
RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE ACTIVITY DESCRIPTION Rheumatoid arthritis (RA) is an inflammatory type of
More informationPATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES
PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES BRIEF SUMMARY PATIENT PACKAGE INSERT YAZ (drospirenone and ethinyl estradiol)
More informationMEDICATION GUIDE. SORIATANE (sor-rye-uh-tane) (acitretin) Capsules
Page 30 Please print: Patient name and address: Telephone: I have fully explained to the patient,, the nature and purpose of the treatment described above and the risks to females of childbearing potential.
More information